Laurent ARNOULD
机构: Département de Pathologie CGFL DIJON
每年引用次数
引用次数
引用: 12,146
H-指数: 53
I10-指数 : 149
出版物: 455
Early predictive value of positron emission tomography with [18F]-fluorodeoxyglucose for the pathologic complete response of primary tumor in breast cancer patients treated by neoadjuvant chemotherapy.
A Berriolo-Riedinger , M Toubeau , J Riedinger , C Touzery
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 33 S167 -S167
2
2006
Correlation between Fluoro-deoxy-glucose uptake with initial prognostic parameters in breast cancer.
J Riedinger , A Berriolo-Riedinger , C Touzery , B Coudert
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 33 S253 -S253
2006
Early predictive value of positron emission tomography with [18F]-fluorodeoxyglucose for the pathologic complete response of primary tumor in breast cancer patients treated by neoadjuvant chemotherapy.
A Berriolo-Riedinger , B Coudert , JM Riedinger , C Touzery
BREAST CANCER RESEARCH AND TREATMENT 94 S59 -S59
2005
Usefulness of dynamic lymphoscintigraphy after subareolar injection of radiocolloid in breast cancer patients
C Boichot , A Berriolo-Riedinger , F Bonnetain , G Fleury
Medecine Nucleaire-Imagerie Fonctionelle et Metabolique 29 ( 12) 807 -816
2005
Dermoid cyst of the ovary-False positive 131-iodine scintiscan for differentiated thyroid carcinoma
S Rudoni , M Toubeau , G Vaillant , L Arnould
PRESSE MEDICALE 27 ( 27) 1379 -1381
1998
Epirubicin dose-response effect in node-positive breast cancer patients is independent of HER2 overexpression: 10-year retrospective analysis of French Adjuvant Study Group 05 trial.
L Arnould , P Fargeot , J Bonneterre , P Fumoleau
BREAST CANCER RESEARCH AND TREATMENT 82 S130 -S131
12
2003
Management of metastatic HER2-positive breast cancer: present and future
S Guiu , B Coudert , L Favier , L Arnould
Bulletin du Cancer 97 ( 3) 365 -383
5
2010
Traitements néo-adjuvants des cancers du sein HER2 positif
Moïse Namer , Michel Héry , Daniel Serin , Marc Spielmann
Cancer du sein: Compte rendu du cours supérieur francophone de cancérologie (Saint-Paul-de-V Vence, ence, 18–20 janvier 2007) 425 -443
1
2007
HER2 positive breast carcinomas: trend in evolution between 1998 and 2008 and relationship with clinicopathological characteristics in a population based study
F Beltjens , A Bertaut , S Pigeonnat , N Pouget
CANCER RESEARCH 72
2012
Thérapies ciblées et cancer du sein métastatique indications pratiques, effets secondaires, bénéfices escomptés. B Coudert, S Guiu, L Favier, C Loustalot
F Mayer , S Causeret , L Arnould , P Fumoleau
56P Real-life data for HRD testing from the only French platform using the Myriad MyChoice test
R Boidot , S Chevrier , P Beacco , A Brasselet
ESMO Open 9
2024
821TiP GREAT: A multicentric cohort of advanced ovarian cancer (AOC) treated in real life with prospective collection of clinical data, tumor sample, and biomarkers (tBRCA, HRD) including genomic putative theranostic markers: A GINECO study
T De La Motte Rouge , D Berton , E Kalbacher , B Asselain
Annals of Oncology 32 S771 -S771
2021
Treatment of idiopathic retroperitoneal fibrosis with tamoxifen.
R Bourouma , D Chevet , F Michel , JP Cercueil
Nephrology Dialysis Transplantation 12 ( 11) 2407 -2410
61
1997
Metastatic renal cell carcinoma to the thyroid gland: report of seven cases and review of the literature
L Benoit , P Favoulet , L Arnould , A Margarot
Annales de Chirurgie 129 ( 4) 218 -223
43
2004
Concurrent lymphoma and metastatic breast carcinoma in the axillary, confounding sentinel lymph-node biopsy
L Benoit , L Arnould , F Collin , J Fraisse
European journal of surgical oncology 30 ( 4) 462 -463
26
2004
Identification of antibodies in sera of breast cancer patients
M Geffard , D Bodet , MP Dabadie , L Arnould
IMMUNOANALYSE ET BIOLOGIE SPECIALISEE 18 ( 5) 248 -253
20
2003
Pathological complete response with neoadjuvant (NA) chemotherapy (trastuzumab (T) and docetaxel (D)) in HER2 positive (3+) locally advanced (LA) breast cancer (BC) patients.
C Molucon , L Vanlemmens , P Chollet , B Weber
BREAST CANCER RESEARCH AND TREATMENT 82 S59 -S59
9
2003
Final pathological complete response (pCr) of neoadjuvant (NA) trastuzumab (T) and docetaxel (D) chemotherapy (CT) in H ER-2 positive (3+) localized breast cancer without possible primary conserving surgery
B Coudert , L Arnould , L Moreau , R Chollet
BREAST CANCER RESEARCH AND TREATMENT 88 S107 -S107
8
2004
Histological and cytopathological cancer specimens: good practice in operating room
L Benoit , P Favoulet , F Collin , L Arnould
Annales de Chirurgie 128 ( 9) 637 -641
7
2003
Bruno Coudert frederique Penault-llorca Sylvain Ladoire Pierre Fumoleau Boidot Romain Charles COUTANT François BRUNOTTE fabrice andre Olivier Humbert Suzette Delaloge ROUZIER Roman Frederique Vegran Paul Cottu Carole Mathelin Jean-Pierre Ghnassia Gilles Paintaud bonnotte bernard Laurence Zitvogel mario campone